Revenue: The sum of all revenue fields included for a company's operating activities.
Acer Therapeutics Inc. (ACER) Revenue data is not available for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-26.24M |
|
-- |
|
-- |
|
$24.61M |
|
$-24.61M |
|
$-1.62M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-26.24M |
|
$-24.61M |
|
$-24.55M |
|
15.77M |
|
15.77M |
|
$-1.66 |
|
$-1.66 |
|
| Balance Sheet Financials | |
$3.52M |
|
$0.21M |
|
$8.11M |
|
$11.62M |
|
$18.95M |
|
$6.05M |
|
$9.43M |
|
$28.39M |
|
$-16.76M |
|
$-24.41M |
|
$-16.76M |
|
19.62M |
|
| Cash Flow Statement Financials | |
$-30.25M |
|
$-0.17M |
|
$20.04M |
|
$12.71M |
|
$2.33M |
|
$-10.38M |
|
$1.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.19 |
|
-- |
|
-- |
|
-0.56 |
|
-0.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
156.54% |
|
107.49% |
|
-225.71% |
|
244.89% |
|
$-0.85 |
|
$-1.93 |
|
$-1.92 |
|